Samsung Biologics has surpassed 82 trillion KRW in market capitalization, overtaking LG Energy Solution to become the third-largest publicly traded company in South Korea. According to the Korea Exchange on the 9th, Samsung Biologics closed at 1.16 million KRW per share on the 7th, up 71,000 KRW (6.52%) from the previous trading session. With a market cap of 82.56 trillion KRW, the company has s..

According to pharmaceutical market research firm IQVIA, Vegzelma achieved a 29% market share in Europe as of Q3 last year, surpassing all competing bevacizumab products, including the original drug. This milestone was reached just two years after its European launch in October 2022. In that quarter alone, Vegzelma's market share increased by 9 percentage points (9%P) compared to the previous qua..

Dr. Soon-Jae Park is regarded as a research and development expert with extensive experience in drug development, clinical trials, technology exports, contract manufacturing (CMO), and business strategy. He is also recognized as an exceptional entrepreneur. Dr. Park majored in biochemistry at Yonsei University and pursued his Ph.D. at Purdue University in the United States. He later worked as a ..